Jailendra Singh
Stock Analyst at Truist Securities
(0.84)
# 4,012
Out of 5,182 analysts
196
Total ratings
25.45%
Success rate
-26.05%
Average return
Main Sectors:
Stocks Rated by Jailendra Singh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DOCS Doximity | Downgrades: Hold | $37 → $29 | $24.01 | +20.78% | 11 | Apr 20, 2026 | |
| PHR Phreesia | Downgrades: Hold | $24 → $11 | $9.54 | +15.30% | 8 | Mar 31, 2026 | |
| ASTH Astrana Health | Maintains: Buy | $37 → $38 | $33.72 | +12.69% | 6 | Mar 13, 2026 | |
| VEEV Veeva Systems | Reiterates: Buy | $275 → $262 | $161.13 | +62.60% | 8 | Mar 5, 2026 | |
| PGNY Progyny | Maintains: Buy | $34 → $28 | $18.17 | +54.10% | 11 | Mar 2, 2026 | |
| PRVA Privia Health Group | Maintains: Buy | $31 → $33 | $23.84 | +38.42% | 9 | Mar 2, 2026 | |
| EVH Evolent Health | Maintains: Buy | $10 → $6 | $3.13 | +91.69% | 9 | Feb 26, 2026 | |
| HIMS Hims & Hers Health | Reiterates: Hold | $37 → $18 | $30.56 | -41.10% | 12 | Feb 24, 2026 | |
| IQV IQVIA Holdings | Maintains: Buy | $290 → $245 | $162.28 | +50.97% | 19 | Feb 19, 2026 | |
| WAY Waystar Holding | Maintains: Buy | $51 → $38 | $25.42 | +49.49% | 4 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $555 → $539 | $410.54 | +31.29% | 7 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $52 | $44.76 | +16.18% | 1 | Jan 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $231 → $222 | $102.17 | +117.28% | 11 | Jan 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $12 → $22 | $9.80 | +124.49% | 1 | Jan 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $48 | $44.29 | +8.38% | 1 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $10 → $9 | $5.75 | +56.52% | 16 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6.5 → $5.5 | $2.31 | +138.10% | 12 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $12 → $7.5 | $5.88 | +27.55% | 7 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $14 | $10.25 | +36.59% | 1 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $160 → $163 | $26.21 | +519.99% | 8 | May 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $13 | $1.89 | +587.83% | 11 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $30 → $24 | $1.02 | +2,252.94% | 2 | Feb 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $14 → $4 | $0.91 | +339.66% | 4 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $58 | $199.85 | -70.98% | 2 | Feb 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $90 → $45 | $1.21 | +3,634.44% | 7 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $230 → $333 | $828.11 | -59.79% | 6 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $9 | $2.43 | +270.37% | 2 | May 19, 2021 |
Doximity
Apr 20, 2026
Downgrades: Hold
Price Target: $37 → $29
Current: $24.01
Upside: +20.78%
Phreesia
Mar 31, 2026
Downgrades: Hold
Price Target: $24 → $11
Current: $9.54
Upside: +15.30%
Astrana Health
Mar 13, 2026
Maintains: Buy
Price Target: $37 → $38
Current: $33.72
Upside: +12.69%
Veeva Systems
Mar 5, 2026
Reiterates: Buy
Price Target: $275 → $262
Current: $161.13
Upside: +62.60%
Progyny
Mar 2, 2026
Maintains: Buy
Price Target: $34 → $28
Current: $18.17
Upside: +54.10%
Privia Health Group
Mar 2, 2026
Maintains: Buy
Price Target: $31 → $33
Current: $23.84
Upside: +38.42%
Evolent Health
Feb 26, 2026
Maintains: Buy
Price Target: $10 → $6
Current: $3.13
Upside: +91.69%
Hims & Hers Health
Feb 24, 2026
Reiterates: Hold
Price Target: $37 → $18
Current: $30.56
Upside: -41.10%
IQVIA Holdings
Feb 19, 2026
Maintains: Buy
Price Target: $290 → $245
Current: $162.28
Upside: +50.97%
Waystar Holding
Feb 18, 2026
Maintains: Buy
Price Target: $51 → $38
Current: $25.42
Upside: +49.49%
Feb 11, 2026
Maintains: Hold
Price Target: $555 → $539
Current: $410.54
Upside: +31.29%
Jan 12, 2026
Initiates: Buy
Price Target: $52
Current: $44.76
Upside: +16.18%
Jan 8, 2026
Downgrades: Hold
Price Target: $231 → $222
Current: $102.17
Upside: +117.28%
Jan 8, 2026
Upgrades: Buy
Price Target: $12 → $22
Current: $9.80
Upside: +124.49%
Jun 16, 2025
Initiates: Buy
Price Target: $48
Current: $44.29
Upside: +8.38%
May 27, 2025
Maintains: Hold
Price Target: $10 → $9
Current: $5.75
Upside: +56.52%
Apr 10, 2025
Maintains: Hold
Price Target: $6.5 → $5.5
Current: $2.31
Upside: +138.10%
Apr 10, 2025
Maintains: Hold
Price Target: $12 → $7.5
Current: $5.88
Upside: +27.55%
Jul 2, 2024
Maintains: Buy
Price Target: $17 → $14
Current: $10.25
Upside: +36.59%
May 24, 2024
Maintains: Hold
Price Target: $160 → $163
Current: $26.21
Upside: +519.99%
May 4, 2022
Maintains: Neutral
Price Target: $16 → $13
Current: $1.89
Upside: +587.83%
Feb 24, 2022
Maintains: Neutral
Price Target: $30 → $24
Current: $1.02
Upside: +2,252.94%
Feb 8, 2022
Downgrades: Neutral
Price Target: $14 → $4
Current: $0.91
Upside: +339.66%
Feb 4, 2022
Maintains: Neutral
Price Target: $60 → $58
Current: $199.85
Upside: -70.98%
Jan 7, 2022
Downgrades: Underperform
Price Target: $90 → $45
Current: $1.21
Upside: +3,634.44%
Jan 7, 2022
Upgrades: Outperform
Price Target: $230 → $333
Current: $828.11
Upside: -59.79%
May 19, 2021
Maintains: Neutral
Price Target: $10 → $9
Current: $2.43
Upside: +270.37%